CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,024,000 | +113.6% | 658,607 | +2.5% | 0.01% | +166.7% |
| Q2 2022 | $15,928,000 | +14.3% | 642,768 | +15.6% | 0.00% | +50.0% |
| Q1 2022 | $13,937,000 | -26.6% | 555,944 | +6.5% | 0.00% | -33.3% |
| Q4 2021 | $18,999,000 | +104.3% | 521,800 | -4.0% | 0.00% | +50.0% |
| Q3 2021 | $9,299,000 | +22.2% | 543,778 | -4.3% | 0.00% | +100.0% |
| Q2 2021 | $7,608,000 | -73.9% | 568,133 | -0.1% | 0.00% | -80.0% |
| Q1 2021 | $29,141,000 | -22.6% | 568,704 | -6.4% | 0.01% | -28.6% |
| Q4 2020 | $37,641,000 | +10.4% | 607,896 | -2.3% | 0.01% | 0.0% |
| Q3 2020 | $34,107,000 | -2.5% | 622,393 | +2.4% | 0.01% | -12.5% |
| Q2 2020 | $34,964,000 | +65.3% | 607,648 | +15.4% | 0.01% | +33.3% |
| Q1 2020 | $21,153,000 | +3.5% | 526,475 | +1.9% | 0.01% | +20.0% |
| Q4 2019 | $20,437,000 | +498.3% | 516,720 | +2.5% | 0.01% | +400.0% |
| Q3 2019 | $3,416,000 | +2.8% | 503,921 | +41.0% | 0.00% | 0.0% |
| Q2 2019 | $3,323,000 | -22.8% | 357,403 | +15.3% | 0.00% | 0.0% |
| Q1 2019 | $4,306,000 | +31.8% | 310,007 | +3.5% | 0.00% | 0.0% |
| Q4 2018 | $3,268,000 | -13.8% | 299,622 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $3,793,000 | +9.2% | 300,109 | +13.8% | 0.00% | 0.0% |
| Q2 2018 | $3,474,000 | -7.5% | 263,766 | -4.5% | 0.00% | 0.0% |
| Q1 2018 | $3,757,000 | +128.5% | 276,280 | -0.0% | 0.00% | – |
| Q4 2017 | $1,644,000 | -19.7% | 276,372 | +0.2% | 0.00% | -100.0% |
| Q3 2017 | $2,048,000 | -21.0% | 275,945 | -0.3% | 0.00% | 0.0% |
| Q2 2017 | $2,592,000 | +40.9% | 276,873 | +9.5% | 0.00% | 0.0% |
| Q1 2017 | $1,840,000 | +0.7% | 252,739 | +2.4% | 0.00% | 0.0% |
| Q4 2016 | $1,828,000 | +28.6% | 246,931 | +4.9% | 0.00% | – |
| Q3 2016 | $1,422,000 | +39.1% | 235,505 | +3.4% | 0.00% | – |
| Q2 2016 | $1,022,000 | +37.6% | 227,673 | -23.7% | 0.00% | – |
| Q1 2016 | $743,000 | -69.4% | 298,208 | -0.4% | 0.00% | -100.0% |
| Q4 2015 | $2,426,000 | +43.5% | 299,443 | +7.2% | 0.00% | 0.0% |
| Q3 2015 | $1,691,000 | -21.3% | 279,417 | +7.0% | 0.00% | 0.0% |
| Q2 2015 | $2,149,000 | +11.1% | 261,145 | +1.9% | 0.00% | 0.0% |
| Q1 2015 | $1,935,000 | +11.7% | 256,378 | +1.0% | 0.00% | 0.0% |
| Q4 2014 | $1,733,000 | +41.5% | 253,755 | -6.8% | 0.00% | – |
| Q3 2014 | $1,225,000 | -19.8% | 272,163 | +4.2% | 0.00% | – |
| Q2 2014 | $1,528,000 | -22.8% | 261,317 | -12.4% | 0.00% | -100.0% |
| Q1 2014 | $1,979,000 | +3.5% | 298,475 | -9.6% | 0.00% | 0.0% |
| Q4 2013 | $1,912,000 | +5.6% | 330,198 | +1.4% | 0.00% | 0.0% |
| Q3 2013 | $1,811,000 | -23.3% | 325,718 | +95.0% | 0.00% | 0.0% |
| Q2 2013 | $2,362,000 | – | 167,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |